ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Hodgkin Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Follicular Lymphoma
Leukemia

Lymphoma trials near San Antonio, TX, USA:

Study of LYL314 in Aggressive Large B-Cell Lymphoma

chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....

Enrolling
Relapsed Non-Hodgkin Lymphoma
Large B-cell Lymphoma
Drug: Cyclophosphamide
Drug: Fludarabine

Phase 1, Phase 2

Lyell Immunopharma

San Antonio, Texas, United States and 26 other locations

Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...

Active, not recruiting
Non Hodgkin Lymphoma
Drug: acalabrutinib
Drug: rituximab (IV)

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

San Antonio, Texas, United States and 31 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Active, not recruiting
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

San Antonio, Texas, United States and 71 other locations

the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients with advanced solid tumors and lymphomas...

Enrolling
Lymphoma, T-Cell
Diffuse Large B Cell Lymphoma
Drug: Enzalutamide
Drug: Tulmimetostat

Phase 1, Phase 2

Novartis
Novartis

San Antonio, Texas, United States of America and 62 other locations

This is a Phase 1/2, multicenter, open-label study to evaluate the safety and efficacy of BEAM-201 in patients with relapsed/refractory T-ALL or T-LL...

Active, not recruiting
T-Cell Lymphoblastic Leukemia/Lymphoma
Lymphoblastic Lymphoma
Biological: BEAM-201

Phase 1, Phase 2

Beam Therapeutics

San Antonio, Texas, United States and 9 other locations

choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy....

Enrolling
Follicular Lymphoma
Drug: Golcadomide
Drug: Rituximab

Phase 3

Celgene
Celgene

San Antonio, Texas, United States and 159 other locations

The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm...

Active, not recruiting
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Venetoclax
Drug: Rituximab

Phase 3

Loxo Oncology
Loxo Oncology

San Antonio, Texas, United States and 179 other locations

participants with relapsed or refractory (r/r) B-Cell non-Hodgkin lymphoma (B-NHL) or frontline high-risk diffuse large B-cell lymphoma...

Enrolling
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Biological: Prizloncabtagene autoleucel (Prizlo-Cel)

Phase 1, Phase 2

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

San Antonio, Texas, United States and 30 other locations

in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with previously untreated mantle cell lymphoma....

Active, not recruiting
Lymphoma, Mantle Cell
Drug: Bendamustine
Drug: Acalabrutinib

Phase 3

Acerta Pharma
Acerta Pharma

San Antonio, Texas, United States and 227 other locations

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have previously received treatm...

Active, not recruiting
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib
Drug: Bendamustine

Phase 3

Loxo Oncology
Loxo Oncology

San Antonio, Texas, United States and 231 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems